Geron (GERN) Treasury Shares (2011 - 2025)

Geron's (GERN) quarterly Treasury Shares came in at $3.1 million in Q4 2025, down 26.94% quarter-over-quarter from $4.3 million in Q3 2025.

Geron (GERN) Treasury Shares (2011 - 2025) Analysis & Trends

Geron has disclosed Treasury Shares across 6 years of filings, most recently posting $3.1 million for Q4 2025.

Treasury Shares for Q4 2025 came in at $3.1 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $3.1 million (changed N/A YoY), and the FY2025 annual result was $3.1 million, changed N/A from the prior year.
Treasury Shares came in at $3.1 million for Q4 2025 at Geron, down from $4.3 million in the prior quarter.
In the past five years, Treasury Shares ranged from a high of $4.4 million in Q1 2025 to a low of $3.1 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Alterity Therapeutics	762,369.55 Bn	762,369.51 Bn	-	-
2	Belite Bio	55,096.00 Bn	55,096.00 Bn	-	-
3	Quantum Biopharma	17,755.80 Bn	17,755.79 Bn	-	-
4	Legend Biotech	3,486.00 Bn	3,485.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,737.42 Bn	1,737.41 Bn	-	-
6	Evaxion A	1,551.28 Bn	1,551.26 Bn	-	-
7	Psyence Biomedical	227.32 Bn	227.31 Bn	-	1.48 Mn
8	Vertex Pharmaceuticals	110.84 Bn	103.59 Bn	2.59 Bn	700,000.00
9	Abivax	91.71 Bn	91.71 Bn	-	-
10	Geron	729,618.77	729,618.77	-	-

Download Data